Synonyms: ACT-539313 | ACT539313
Compound class:
Synthetic organic
|
|
References |
1. Kaufmann P, Ort M, Golor G, Kornberger R, Dingemanse J. (2020)
First-in-human study with ACT-539313, a novel selective orexin-1 receptor antagonist. Br J Clin Pharmacol, 86 (7): 1377-1386. [PMID:32067262] |
2. Williams JT, Bolli MH, Brotschi C, Sifferlen T, Steiner MA, Treiber A, Gatfield J, Boss C. (2024)
Discovery of Nivasorexant (ACT-539313): The First Selective Orexin-1 Receptor Antagonist (SO1RA) Investigated in Clinical Trials. J Med Chem, 67 (4): 2337-2348. [PMID:38331429] |